Form 4: NHI Director Candice Todd Awarded Restricted Stock
Director Compensation Update
National Health Investors Inc. director Candice W. Todd received a grant of 1,268 restricted common shares, vesting in March 2027.
Summary
- Candice W. Todd, a Director of National Health Investors Inc. (NHI), was awarded 1,268 shares of common stock.
- The shares were granted on March 3, 2026, at a price of $0 per share.
- These shares are restricted stock and will vest in full on March 3, 2027, contingent upon her continued service as a director.
- Following this transaction, Ms. Todd beneficially owns a total of 2,563 shares of NHI common stock.
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a standard corporate governance action, reflecting ongoing director compensation and alignment of interests, which is generally positive for stability but not a significant market mover.
Positives
- The grant of restricted stock aligns the director's interests with long-term shareholder value.
- The vesting schedule encourages continued service and commitment from the director.
Risks
- The restricted stock grant is subject to the reporting person's continued service as a director through the vesting date of March 3, 2027.
Future Outlook
The restricted stock vests on March 3, 2027, contingent on continued service, indicating an expectation of the director's ongoing involvement with the company.
Industry Context
StockSavvy.ai notes that restricted stock grants are a common form of executive and director compensation in the real estate investment trust (REIT) sector, including healthcare REITs like NHI. This practice aims to align the interests of leadership with long-term company performance and shareholder returns, a standard governance practice across the industry.
Comparison to Industry Standards
- Restricted stock grants are a standard compensation practice for directors in publicly traded companies, including REITs.
- The vesting period of approximately one year is common for such grants, similar to practices seen in peer healthcare REITs like Ventas (VTR) or Welltower (WELL), which often use equity awards to incentivize long-term commitment.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Director Compensation | Grant of 1,268 restricted common shares to Director Candice W. Todd as part of her compensation. | 03/03/2026 | Aligns director's long-term interests with shareholders and incentivizes continued service. |
Stakeholder Impact
- Shareholders: The grant aligns the director's interests with long-term shareholder value.
Next Steps
- The restricted stock will vest on March 3, 2027, subject to continued service.
Key Dates
| Date | Description |
|---|---|
| 03/03/2026 | Date of restricted stock grant to Director Candice W. Todd. |
| 03/04/2026 | Date the Form 4 was signed. |
| 03/03/2027 | Vesting date for the restricted stock, subject to continued service. |
Recommendation
holdThis Form 4 filing details a routine restricted stock grant to a director, which is a standard compensation practice aimed at aligning interests. It does not provide new information regarding the company's operational performance, financial health, or strategic direction that would warrant a change in investment recommendation. Therefore, a "hold" recommendation is appropriate, maintaining existing positions based on broader company fundamentals rather than this specific insider transaction.
Keywords
National Health Investors, NHI, Candice W Todd, Director, Restricted Stock, Stock Grant, Beneficial Ownership, Form 4, Insider Transaction, Corporate Governance
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.